The efficacy and safety of PD-L1-specific CAR-T in advanced gastric cancer

被引：0
|
作者：
Park, Hye-Seong
Choi, Eun-Ji
Yu, Jae-In
Lee, Kyung-Sik
Lim, Yeo-Jin
Choi, Se-Ryeong
Choi, Yoonjoo
Park, Bum Chan
Park, Jae Eun
Kim, Mihwa
Lee, Je-Jung
Rhee, Joon Haeng
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-889
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
889
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PD1-TLR10 fusion protein enhances the antitumor efficacy of CAR-T cells in colon cancer
    Peng, Youguo
    Huang, Zhiming
    Wu, Yafei
    Wu, Ting
    Lu, Jinhua
    Zhang, Jie
    Liu, Xiang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 148
  • [22] A PD-L1-targeting chimeric switch receptor enhances efficacy of CAR-T cell for pleural and peritoneal metastasis
    Ma, Qizhi
    He, Xia
    Zhang, Benxia
    Guo, Fuchun
    Ou, Xuejin
    Yang, Qiyu
    Shu, Pei
    Chen, Yue
    Li, Kai
    Gao, Ge
    Zhu, Yajuan
    Qin, Diyuan
    Tang, Jie
    Li, Xiaoyu
    Jing, Meng
    Zhao, Jian
    Mo, Zeming
    Liu, Ning
    Zeng, Yao
    Zhou, Kexun
    Feng, Mingyang
    Liao, Weiting
    Lei, Wanting
    Li, Qiu
    Li, Dan
    Wang, Yongsheng
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [23] PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo
    Liao, Qibin
    Mao, Yunyu
    He, Huan
    Ding, Xiangqing
    Zhang, Xiaoyan
    Xu, Jianqing
    BIOMARKER RESEARCH, 2020, 8 (01)
  • [24] A PD-L1-targeting chimeric switch receptor enhances efficacy of CAR-T cell for pleural and peritoneal metastasis
    Qizhi Ma
    Xia He
    Benxia Zhang
    Fuchun Guo
    Xuejin Ou
    Qiyu Yang
    Pei Shu
    Yue Chen
    Kai Li
    Ge Gao
    Yajuan Zhu
    Diyuan Qin
    Jie Tang
    Xiaoyu Li
    Meng Jing
    Jian Zhao
    Zeming Mo
    Ning Liu
    Yao Zeng
    Kexun Zhou
    Mingyang Feng
    Weiting Liao
    Wanting Lei
    Qiu Li
    Dan Li
    Yongsheng Wang
    Signal Transduction and Targeted Therapy, 7
  • [25] PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo
    Qibin Liao
    Yunyu Mao
    Huan He
    Xiangqing Ding
    Xiaoyan Zhang
    Jianqing Xu
    Biomarker Research, 8
  • [26] Clinical study of PD-1 disrupted anti-MUC1 CAR-T cells in patients with advanced oesophageal cancer
    Chen, S.
    Lin, Y.
    Cui, Y.
    Zhou, C.
    An, H.
    Huang, J.
    Su, Z.
    McGowan, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S186 - S186
  • [27] Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies
    Najafi, Sajad
    Mortezaee, Keywan
    LIFE SCIENCES, 2024, 338
  • [28] Novel technologies for improving the safety and efficacy of CAR-T cell therapy
    Keisuke Ohta
    Yukimi Sakoda
    Koji Tamada
    International Journal of Hematology, 2023, 117 : 647 - 651
  • [29] Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies
    de Lima, Marcos
    Di Rocco, Alice
    Ribera, Jose-Maria
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [30] Lymphoma immunotherapy: Efficacy, safety, and accessibility to CAR-T therapy for lymphomas
    Borchmann, Peter
    HEMASPHERE, 2018, 2 : 93 - 95
12345